510(k) · Cleared
ClearedDade Thrombin Reagent
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Dade Behring, Inc. · KQJ System, Fibrinogen Determination
Cleared on Jun 29, 2005 after a 76-day review. The summary cites one number, which could not be confirmed as its predicate (see the table below).
- Decided
- Jun 29, 2005
- Review
- 76 days
- Class
- Class II
- Product code
- KQJ
- Recalls
- None
- Predicates
- 1
The summary cites one number, which could not be confirmed as its predicate (see the table below).
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in KQJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new KQJ device
- #1 K251968 HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XLscore 10.0 · 2 generations · no Class I recall
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.
| Type | Number | Device | Decided |
|---|---|---|---|
| Kept off the family tree | K860038 | Dade® Thrombin Reagent The summary prints BK860038, a CBER number, which our reading took as K860038, which is not in FDA’s 510(k) list. Kept off the family tree. Summary page 1…3. Identification of the Legally Marketed Device: Dade® Fibrinogen Determination Reagents kit (Pre-1976) and Dade® Thrombin Reagent (BK860038) 4. Device Description: Fibrinogen is a plasma protein which is converted from a soluble protein to an ins… | |
| * | — | Dade® Fibrinogen Determination Reagents kit (Pre-1976) Named without a submission number |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
How does its category compare?
All KQJ devicesKQJ System, Fibrinogen Determination: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · KQJ
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · KQJ
Too few KQJ 510(k)s in any year since 2007 to give a median.
Recalls per year · KQJ
No recall names KQJ since 2007.
Adverse event reports per year · KQJ
2in 2024
MAUDE reports naming product code KQJ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 1 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 1 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 1 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 2 |
| 2025 | 1 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
For use in the quantitative determination of fibrinogen in plasma and to accelerate coagulation of anticoagulated samples for immunohematology studies.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K050928 · printed Nov 4, 2026
Cite this page
510(k) Report. “K050928: Dade Thrombin Reagent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K050928
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Page last updated Nov 3, 2026